Highland Capital Sets its Eyes on the Asian Market

Highland Capital Management is an investment advisory firm that is based in Dallas, Texas. The company was founded in 1993. It has close to $15 billion assets under management. It was founded by Mark Okada and James Dondero. James is the current president of the firm. The firm specializes in alternative investments, collateralized loan obligations, and credit strategies.

 

Highland Capital was invited to visit the Nasdaq MarketSite in Times Square on 12th of October. The company was celebrating the re-listing of the Highland iBoxx Senior Loan ETF. The Senior Loan ETF is managed by Highland Capital Management Fund Advisors. It focuses on retail. Mark Okada is the co-founder of Highland Capital. He honored the occasion by ringing the closing bell of the day.

Highland Capital Management Korea announced that they had raised $147 million for a private equity fund. The anchor investor of the fund is the Nation Pension Service of South Korea. It is valued at half a trillion dollars. The investors of the fund decided to set out with specific objectives including the investment returns. One of the goals is that the fund will invest in opportunities in China and the US.

 

Stonebridge Capital is a Korean private equity firm. It will co-manage the fund. Highland Capital entered into a partnership with the venture capital firm because of its knowledge and experience in the Korean market. This is the first equity fund from Highland Capital that is focused on healthcare in Asia. This was done on a direct basis or through multi-purpose funds despite the fact that the firm had made investments in the sector in the past.

 

Carl Moore is the managing director of Highland’s private equity group. Carl said that healthcare was one of the sectors that they had massively invested. Highland has $1.5 B in healthcare assets under management. This is close to ten percent of their total assets. He said that the fund would focus on healthcare companies in Asia and North America. Matt Jameson who is the co-head of private equity at the firm said that several companies were disrupting the healthcare. He pointed out that this availed many opportunities for investors in the industry.

Leave a Reply

Your email address will not be published. Required fields are marked *